22Jan
Blog: Cooley’s 2020 Life Sciences M&A Year in Review
General Trends in Life Sciences M&A - If 2019 was the year of life sciences mega-deals, 2020 was the year of COVID-19, as the global pandemic permeated every aspect of the dealmaking landscape, with the life sciences sector being no exception. COVID-19 drove unprecedented levels of collaboration among biopharmaceutical companies seeking to develop a vaccine, leading to an accelerated research and development process that allowed not just one—but two—vaccines to be approved by the FDA in...
By:
Cooley LLP
Related
California employers got a win with a recent court decision that an employee’s promise not to compe...
Read More >
Battery Manufacturer Rescinded Its Job Offer Based on Unfounded Fears of Safety, Federal Agency Char...
Read More >
Representations and warranties play an important role in M&A agreements by providing valuable disclo...
Read More >
The Ministry of Manpower has issued Ministerial Decision 47/2020 (the MD). The MD adds "sales repres...
Read More >
Although employees face additional taxes and decreased benefits resulting from employer failures inv...
Read More >
This blog was originally published on July 2, 2019 and revised to include new additional information...
Read More >